CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
November 21st 2024
Aerobic exercise improved self-reported cognitive function in women undergoing chemotherapy for breast cancer but had no effect on objective cognitive function.
Talzenna-Novel Drug Combo Continues to Be Studied in Patients With Triple-Negative Breast Cancer
May 12th 2022Findings from an early-stage trial assessing Talzenna in combination with a novel drug, known as ZEN-3694, have led the manufacturer to initiate a later-stage study in patients with triple-negative breast cancer.
FDA Approves Enhertu for Subset of Patients with Metastatic Breast Cancer
May 5th 2022The FDA’s approval of Enhertu in this setting, according to an expert, marks an important milestone and will allow patients with unresectable or metastatic HER2-positive breast cancer to be treated in an earlier line, with the possibility of delaying disease progression.
Kisqali Combo Allows Patients With Advanced Breast Cancer to Live Longer, With ‘More Quality Time’
May 4th 2022Updated trial results showed that the use of Kisqali plus fulvestrant was associated with an approximate 33% decrease in risk of death for women with HR-positive, HER2-negative advanced breast cancer.
Enhertu Granted Breakthrough Therapy Designation for Unresectable/Metastatic Breast Cancer Treatment
April 28th 2022After Enhertu showed promising clinical trial results, the Food and Drug Administration agreed to speed up the development and review of the drug for certain patients with unresectable or metastatic breast cancer.